MONDAY, Aug. 30, 2021 (HealthDay News)
Demand for Abbott Laboratories’ at-home COVID-19 exams has reached “unprecedented” amounts and source may perhaps be restricted in the coming weeks, the company claims.
Sales have skyrocketed thanks to the surge in cases pushed by the extremely transmissible Delta variant, CNN reported.
“We’re looking at unprecedented demand from customers as case charges increase — and we’ve been scaling up production because Delta became the dominant strain and new CDC advice referred to as for a reprioritization of testing,” Abbott spokesperson John Koval told CNN.
“Nowadays, there are tens of millions of BinaxNOW exams in a variety of options and source chains. We’re performing with our prospects to make sure exams get to the place they’re most necessary and we are ramping again up, as we did past year,” Koval stated. “There will be some source constraints about the coming weeks as amplified capability arrives on the internet.”
Two other COVID-19 check builders — Labcorp and Quest Diagnostics — also told CNN they’re looking at amplified demand from customers.
“We proceed to see increases in demand from customers for COVID-19 PCR testing thanks to Delta and as the faculty year begins,” Christopher Allman-Bradshaw, a spokesperson for Labcorp, told CNN. “We report figures on a quarterly basis that we have noticed an enhance in testing as caseloads increase.”
Quest Diagnostics has noticed a similar increase in demand from customers for diagnostic testing.
“Although COVID-19 molecular diagnostic testing demand from customers and positivity charges have climbed in new weeks thanks to the nationwide enhance in COVID-19 cases, we are carrying out and reporting the greater part of COVID-19 exams inside of a single working day,” Kim Gorode, a spokesperson for Quest Diagnostics, told CNN. “We have sufficient capability, but are introducing molecular check devices to bolster readiness in pick laboratories in the Southeast and Southwest, the place demand from customers is comparatively superior.”
A lot more details
Go to the U.S. Centers for Illness Manage and Avoidance for more on COVID-19 testing.
Copyright © 2021 HealthDay. All legal rights reserved.